Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jaktinib in severe Alopecia Areata
NCT04034134Phase 2Completed
- Sponsor
- Zelgen
- Start
- Nov 2019
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of jaktinib in alopecia areata, sponsored by Zelgen. Started Nov 2019; status: completed.
02
Drugs
jaktinib
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT04034134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04034134.